- Home
- IPW vs NVNO Comparison
IPW vs NVNO Comparison
Compare IPW & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPW
- NVNO
- Stock Information
- Founded
- IPW 2018
- NVNO 1987
- Country
- IPW United States
- NVNO United States
- Employees
- IPW N/A
- NVNO N/A
- Industry
- IPW Catalog/Specialty Distribution
- NVNO Medical/Dental Instruments
- Sector
- IPW Consumer Discretionary
- NVNO Health Care
- Exchange
- IPW Nasdaq
- NVNO Nasdaq
- Market Cap
- IPW 16.3M
- NVNO 16.7M
- IPO Year
- IPW 2021
- NVNO N/A
- Fundamental
- Price
- IPW $0.54
- NVNO $0.95
- Analyst Decision
- IPW
- NVNO
- Analyst Count
- IPW 0
- NVNO 0
- Target Price
- IPW N/A
- NVNO N/A
- AVG Volume (30 Days)
- IPW 2.9M
- NVNO 686.9K
- Earning Date
- IPW 11-13-2025
- NVNO 10-30-2025
- Dividend Yield
- IPW N/A
- NVNO N/A
- EPS Growth
- IPW N/A
- NVNO N/A
- EPS
- IPW N/A
- NVNO N/A
- Revenue
- IPW $74,105,251.00
- NVNO N/A
- Revenue This Year
- IPW $8.31
- NVNO N/A
- Revenue Next Year
- IPW $77.15
- NVNO N/A
- P/E Ratio
- IPW N/A
- NVNO N/A
- Revenue Growth
- IPW N/A
- NVNO N/A
- 52 Week Low
- IPW $0.41
- NVNO $0.67
- 52 Week High
- IPW $2.05
- NVNO $5.62
- Technical
- Relative Strength Index (RSI)
- IPW 50.06
- NVNO 33.18
- Support Level
- IPW $0.50
- NVNO $0.85
- Resistance Level
- IPW $0.58
- NVNO $0.99
- Average True Range (ATR)
- IPW 0.09
- NVNO 0.06
- MACD
- IPW 0.00
- NVNO 0.10
- Stochastic Oscillator
- IPW 7.58
- NVNO 49.94
About IPW iPower Inc.
iPower Inc is online hydroponic equipment and accessory retailer and supplier in North America. The company sells products through own website as well as online channel partners that include Amazon, Walmart, and eBay.
About NVNO enVVeno Medical Corporation
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.